Tenecteplase for Acute Ischemic Stroke
Join us as Dr. Anna Barminova describes the use of Tenecteplase (TNK) as an alternative intravenous thrombolytic agent for the treatment of acute ischemic stroke.
Target Audience
- Physicians
- Advanced Practice Nurses
- Physician Assistant
- Registered Nurses
Learning Objectives
Learners will be able to;
- Describe what Tenecteplase (TNK) is, how it works and how it is different from Alteplase.
- Review the clinical evidence for using Tenecteplase (TNK) in Acute Ischemic Stroke (AIS).
- Define AHA/ASA current guidelines regarding Tenecteplase (TNK).
- Recognize dosing and administration for Tenecteplase (TNK) as well as possible side effects.
- Discuss current research and future directions of Tenecteplase (TNK).
Speaker(s)
Anna Barminova, MD
has no relevant financial relationships to disclose at this time.
Moderator(s)
Debra Chionis, MS, ACE-MES, ACSM-CEP
has no relevant financial relationships to disclose at this time.
Peer Reviewer(s)
Michelle Boudreau, D.O.
has no relevant financial relationships to disclose at this time.
Planner(s)
Caitlyn Boyd, MHA, MSN, RN, CPHQ, CPAHA-TeleStroke
has no relevant financial relationships to disclose at this time.
Muhammad Saeed, Bcom
has no relevant financial relationships to disclose at this time.
Theresa Sevilis, D.O.
has a financial relationship (Stock) with Moderna;.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
TeleSpecialists designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Nursing Contact HoursThis nursing continuing professional development activity was approved by the Emergency Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.